Adagio Medical Holdings, Inc. (ADGM) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US00534B1008

Price
1.93 USD
Market cap
1.07 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Adagio Medical Holdings, Inc. financials

Fiscal year2025
Revenue0.00 USD
Gross profit-684,000.00 USD
Operating income-21.89 m USD
EBIT-22.66 m USD
Net income-25.08 m USD
Diluted EPS – continuing operations-1.51 USD

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Adagio Medical Holdings, Inc.

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.